⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqCM

LQDA

Liquidia Corporation

Healthcare · Drug Manufacturers - Specialty & Generic

69.12USD

+1.4400 (+2.13%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
1)

Comparable Revenue

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY15.9M17.5M14.0M158.3M738.9M1.2B
Q13.5M4.5M3.0M3.1M132.9M—
Q23.9M4.8M3.7M8.8M171.7M—
Q33.2M3.7M4.4M54.3M205.9M—
Q45.4M*4.5M*2.9M*92.0M*228.5M—
2)

Comparable Earnings Per Share

EM »

Revenue

 

 

QuarterlyAnnual
Reported
(USD)202220232024202520262027
FY-.670-1.21-1.63-.8003.225.65
Q1-.300-.180-.400-.450.520—
Q2-.150-.360-.380-.490.740—
Q3-.140-.240-.400-.040.958—
Q4-.107*

Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.

-.422*
-.489*
.169*
1.00
—